Millendo Therapeutics, Inc. (TPST) is a publicly traded company in the Unknown sector. Across all available filings, 7 corporate insiders have executed 14 transactions totaling $6.1M, demonstrating a bullish sentiment with $4.1M in net insider flow. The most recent transaction on Aug 12, 2024 involved a sale of 387,999 shares valued at $426.8K.
No significant insider buying has been recorded for TPST in the recent period.
No significant insider selling has been recorded for TPST in the recent period.
Based on recent SEC filings, insider sentiment for TPST is bullish with an Insider Alignment Score of 84/100 and a net flow of $4.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Millendo Therapeutics, Inc. (TPST) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 7 insiders are actively trading TPST stock, having executed 14 transactions in the past 90 days. The most active insider is Thomas Woiwode (Executive), who has made 4 transactions totaling $5.0M.
Get notified when executives and directors at TPST file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Capital Vi, L.p. Versant Venture | Executive | Sale | 387,999 | $1.10 | $426.8K | |
| Aug 8, 2024 | Capital Vi, L.p. Versant Venture | Executive | Sale | 400,000 | $1.35 | $540.0K | Large |
| Jul 3, 2024 | R. Brady Stephen | Executive | Purchase | 35,000 | $2.11 | $73.8K | |
| Jul 2, 2024 | Whiting Samuel | Executive | Purchase | 4,672 | $2.13 | $10.0K | |
| Apr 29, 2022 | Woiwode Thomas | Executive | Purchase | 2,118,644 | $2.36 | $5.0M | Large |
| Jan 7, 2022 | W. Dubensky Thomas | Executive | Purchase | 2,000 | $4.78 | $9.6K | |
| Jan 6, 2022 | Whiting Samuel | Executive | Purchase | 1,700 | $4.80 | $8.2K | |
| Jun 25, 2021 | Lorenzo Pierre | Executive | Award | 53 | $N/A | $0 | |
| Jun 25, 2021 | Woiwode Thomas | Executive | Award | 997,940 | $N/A | $0 | |
| Jun 25, 2021 | Woiwode Thomas | Executive | Award | 1,171,094 | $N/A | $0 | |
| Jun 25, 2021 | Woiwode Thomas | Executive | Award | 7,377 | $N/A | $0 | |
| Jun 25, 2021 | W. Dubensky Thomas | Executive | Award | 111,343 | $N/A | $0 | |
| Jun 25, 2021 | Xu Stella | Executive | Award | 579,710 | $N/A | $0 | |
| Jun 25, 2021 | Whiting Samuel | Executive | Award | 201 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 5 | $5.1M | 84.1% |
Sale(S) | 2 | $966.8K | 15.9% |
Award(A) | 7 | $0 | 0.0% |
Insiders at Millendo Therapeutics, Inc. are accumulating shares at an accelerated pace. With 7 insiders making 14 transactions totaling $5.1M in purchases versus $966.8K in sales, the net buying activity of $4.1M signals strong executive confidence. Thomas Woiwode (Executive) leads the buying activity with $5.0M in transactions across all time.